Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

X4 Pharmaceuticals (XFOR) Cost of Revenue (2024 - 2025)

Historic Cost of Revenue for X4 Pharmaceuticals (XFOR) over the last 2 years, with Q3 2025 value amounting to $351000.0.

  • X4 Pharmaceuticals' Cost of Revenue rose 5462.56% to $351000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 105050.51%. This contributed to the annual value of $797000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that X4 Pharmaceuticals reported Cost of Revenue of $351000.0 as of Q3 2025, which was up 5462.56% from $326000.0 recorded in Q2 2025.
  • In the past 5 years, X4 Pharmaceuticals' Cost of Revenue registered a high of $4.7 million during Q1 2025, and its lowest value of $227000.0 during Q3 2024.